SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks"
- PMID: 37985854
- PMCID: PMC10805730
- DOI: 10.1038/s41423-023-01104-y
SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks"
Abstract
An ancient conflict between hosts and pathogens has driven the innate and adaptive arms of immunity. Knowledge about this interplay can not only help us identify biological mechanisms but also reveal pathogen vulnerabilities that can be leveraged therapeutically. The humoral response to SARS-CoV-2 infection has been the focus of intense research, and the role of the innate immune system has received significantly less attention. Here, we review current knowledge of the innate immune response to SARS-CoV-2 infection and the various means SARS-CoV-2 employs to evade innate defense systems. We also consider the role of innate immunity in SARS-CoV-2 vaccines and in the phenomenon of long COVID.
Keywords: Antiviral targets; Cytokines; Inflammation; Innate immune response; Interferon; SARS-CoV-2.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Liu WJ, Liu P, Lei W, Jia Z, He X, Shi W, et al. Surveillance of SARS-CoV-2 at the Huanan Seafood Market. Nature. 2023:1–3. 10.1038/s41586-023-06043-2. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
